SEC Form D · Amendment · filed October 16, 2020
Novita Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (17)
Christy Y. Shue · New York, NYExec · DirectorXin-Yun Y. Huang · New York, NYDirectorChenjian J. Li · New York, NYDirectorJue J. Zhang · New York, NYExec · DirectorDavid J. Moy · New York, NYExecDaniel Sparks · Stamford, CTExecElliot S. Favus · Mt. Pleasant, SCExec · DirectorJustin Mahoney · Stamford, CTExec · DirectorKevin Gasvoda · Stamford, CTDirectorTony W. Bartsh · Mt. Pleasant, SCDirectorJonathan J. Zhu · New york, NYDirectorStephen D. Schroeder · San Francisco, CAExec · DirectorPassco Parker Manager, LLC · Irvine, CADirectorSacks Ventures GP I, LLC · SAN FRANCISCO, CAExec · DirectorPassco Parker Depositor, LLC · Irvine, CAExecRichard O. Fortmann · San Francisco, CADirectorJonathan J. Zhu · New york, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗